Empiget (Empagliflozin 10mg) Per Card of 7 Tablets

Description Empagliflozin is an oral SGLT2 inhibitor (Sodium-Glucose Co-Transporter-2 inhibitor) that helps reduce blood sugar by: Preventing glucose reabsorption in the kidneys Increasing glucose excretion through urine 2. Uses Empagliflozin is prescribed for: Type 2 Diabetes Mellitus: To improve glycemic control Heart Failure with reduced ejection fraction (HFrEF): Reduces hospitalization risk and cardiovascular death Chronic Kidney Disease (CKD): Slows progression and reduces cardiovascular complications Note: Not typically used for Type 1 diabetes or diabetic ketoacidosis. 3. Dosage Standard Dose: 10 mg once daily, with or without food May be increased to 25 mg daily if needed and tolerated 4. Side Effects Common: Increased urination Thirst Urinary tract infections (UTIs) Genital infections (yeast) Serious (seek medical attention): Ketoacidosis (even with normal blood sugar): Symptoms include nausea, vomiting, fatigue, difficulty breathing Dehydration Hypoglycemia (when combined with insulin or sulfonylureas) Kidney function decline (especially in older adults or those with kidney disease) 5. Precautions Stay hydrated Monitor blood sugar regularly Inform your doctor if you have: Kidney disease Liver issues History of urinary/genital infections Avoid use: During pregnancy/breastfeeding unless advised In patients with Type 1 diabetes or prone to katoacidosis 6. Drug Interactions May interact with: Diuretics (increased risk of dehydration) Insulin/sulfonylureas (risk of low blood sugar) Blood pressure meds.